source
- FDA Requests Public Feedback on Designing Early-Phase Trials for Psychedelic Drug IbogaineThe U.S. Food and Drug Administration announced it is seeking comments from the public on how to structure early-phase clinical studies of ibogaine, a plant-derived psychoactive compound. The agen…
- Mimetic Medicines' peptide reduces pain-related sodium channels in mice, offering new neuropathic pain strategyResearchers at Mimetic Medicines tested a short lipidated peptide (SLiP) in mice and found it lowered the presence of Nav1.8 sodium channels on sensory neuron membranes. Reducing these channels hel…